| Literature DB >> 29316264 |
Jacek Stepniewski1, Tomasz Pacholczak1, Aniela Skrzypczyk1, Maciej Ciesla1, Agata Szade1, Krzysztof Szade1, Romain Bidanel1, Agnieszka Langrzyk2, Radoslaw Grochowski1, Felix Vandermeeren1, Neli Kachamakova-Trojanowska1, Mateusz Jez1, Grazyna Drabik3, Mahito Nakanishi4, Alicja Jozkowicz1, Jozef Dulak1,2.
Abstract
Cellular stress can influence efficiency of iPSCs generation and their differentiation. However, the role of intracellular cytoprotective factors in these processes is still not well known. Therefore, we investigated the effect of HO-1 (Hmox1) or Nrf2 (Nfe2l2), two major cytoprotective genes. Hmox1-/- fibroblasts demonstrated decreased reprogramming efficiency in comparison to Hmox1+/+ cells. Reversely, pharmacological enhancement of HO-1 resulted in higher number of iPSCs colonies. Importantly, elevated level of both p53 and p53-regulated miR-34a and 14-3-3σ was observed in HO-1-deficient fibroblasts whereas downregulation of p53 in these cells markedly increased their reprogramming efficiency. In human fibroblasts HO-1 silencing also induced p53 expression and affected reprogramming outcome. Hmox1+/+ and Hmox1-/- iPSCs similarly differentiated in vitro to cells originating from three germ layers, however, lower number of contracting cells was observed during this process in HO-1-deficient cells indicating attenuated cardiac differentiation. Importantly, silencing of Hmox1 in murine ESC using CRISPR/Cas-9 editing also impaired their spontaneous cardiac differentiation. Decreased reprogramming efficiency was also observed in Nrf2-lacking fibroblasts. Reversely, sulforaphane, a Nrf2 activator, increased the number of iPSCs colonies. However, both Nfe2l2+/+ and Nfe2l2-/- iPSCs showed similar pluripotency and differentiation capacity. These results indicate that regulation of HO-1 expression can further optimize generation and cardiac differentiation of iPSCs.Entities:
Keywords: CRISPR/Cas-9; cardiomyocyte; embryonic stem cells; heme oxygenase-1 (HO-1); induced pluripotent stem cells; miR-34a; microRNA; nuclear factor (erythroid-derived 2)-like factor 2 (Nrf2); p53; reprogramming
Mesh:
Substances:
Year: 2018 PMID: 29316264 DOI: 10.1002/iub.1711
Source DB: PubMed Journal: IUBMB Life ISSN: 1521-6543 Impact factor: 3.885